Chrysalis NAV slides further as board offers wind-up to shareholders
Falling valuations continue to harm the growth-orientated trust
Chrysalis Investments
-
-
Jupiter snubs unquoteds as it ditches Starling
Meanwhile Chrysalis has forked out £20m to increase its stake in the bank
-
Signs of life at Chrysalis after 2022 to forget
NAV was down 13% in its fourth quarter, but the trust has perked up since
-
Chrysalis vindicated for ditching Revolution Beauty at hefty discount?
Shares in the firm were suspended in September, with the trust selling out at a 90% loss in November
-
Chrysalis slashes manager fees after hefty January pay out
Trust has agreed to lower the overall fee to 12.5% of adjusted NAV above a high-water mark
-
Chrysalis ditches stake in struggling Revolution at nearly 90% loss
In just over a year the value of the investment had plummeted to £5m
-
Woes continue for Chrysalis as Starling keeps heading south
NAV has fallen more than 40% in a year
-
Jupiter to sell Starling stake but Chrysalis holds on
The challenger bank is eyeing an IPO before the end of 2023
-
Chrysalis suffers NAV blow as stock suspension warning rattles Revolution Beauty shares
Cosmetics group admits it is unlikely to publish its final audited results by the end of the month
-
Wefox valuation miss adds to Chrysalis woes
Just a day after the value of ‘buy now pay later’ juggernaut Klarna took a massive hit
-
More pain for Chrysalis shares as Klarna valuation slashed to £5.6bn
Co-manager Watts says new price tag does not reflect ‘buy now pay later’ firm’s progress since initial investment
-
Chrysalis puts a pin in share buybacks as discount slumps to 55%
Co-managers Williamson and Watts to redouble their efforts on existing holdings, 60% which have yet to break even
